DMP 266 on the horizon.
Vazquez
E
E
D000480:Alkynes; D048588:Benzoxazines; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D010078:Oxazines / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use*; D018579:Patient Selection; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use*; D019562:Viral Load
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; C098320:efavirenz